Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Ter Heine

Showing results (101-110 of 160) with videos related to

Pageof 16
Sort By:
Frontiers in Pharmacology|January 4, 2021
A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of ConceptStan J F Hartman, Joost G E Swaving, Stijn W van Beek, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink DosingEline W Muilwijk, Dylan W de Lange, Jeroen A Schouten, et al.
British Journal of Clinical Pharmacology|December 29, 2021
Effects of dalteparin on anti-Xa activities cannot be predicted in critically ill COVID-19 patientsCharlotte D C C van der Heijden, Rob Ter Heine, Emma J Kooistra, et al.
Clinical Genitourinary Cancer|December 18, 2018
Bone-Targeting Radiopharmaceuticals as Monotherapy or Combined With Chemotherapy in Patients With Castration-Resistant Prostate Cancer Metastatic to BoneEsther W Bouman-Wammes, John M H de Klerk, Haiko J Bloemendal, et al.
British Journal of Clinical Pharmacology|June 22, 2025
Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patientsJaap W A Mouton, Julian D Machiels, Arthur M A Pistorius, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2023
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot StudyPaul A G de Klaver, Ron J Keizer, Rob Ter Heine, et al.
British Journal of Clinical Pharmacology|September 27, 2018
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedureLoek A W de Jong, Fortuné M K Elekonawo, Philip R de Reuver, et al.
Digestive Diseases and Sciences|March 15, 2023
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's DiseaseTessa Straatmijer, Vince B C Biemans, Dirk Jan A R Moes, et al.
Therapeutic Drug Monitoring|January 23, 2026
Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeAstrid Heida, Mendy Ter Avest, Ron J Keizer, et al.
Pageof 16

Showing results (101-110 of 160) with videos related to

Sort By:
Pageof 16
Frontiers in Pharmacology|January 4, 2021
A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of ConceptStan J F Hartman, Joost G E Swaving, Stijn W van Beek, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2019
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modellingStein Schalkwijk, Rob Ter Heine, Angela Colbers, et al.
Antimicrobial Agents and Chemotherapy|August 21, 2020
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink DosingEline W Muilwijk, Dylan W de Lange, Jeroen A Schouten, et al.
British Journal of Clinical Pharmacology|December 29, 2021
Effects of dalteparin on anti-Xa activities cannot be predicted in critically ill COVID-19 patientsCharlotte D C C van der Heijden, Rob Ter Heine, Emma J Kooistra, et al.
Clinical Genitourinary Cancer|December 18, 2018
Bone-Targeting Radiopharmaceuticals as Monotherapy or Combined With Chemotherapy in Patients With Castration-Resistant Prostate Cancer Metastatic to BoneEsther W Bouman-Wammes, John M H de Klerk, Haiko J Bloemendal, et al.
British Journal of Clinical Pharmacology|June 22, 2025
Population pharmacokinetics and optimized dosing of cefuroxime in critically ill patientsJaap W A Mouton, Julian D Machiels, Arthur M A Pistorius, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 15, 2023
Early At-Home Measurement of Adalimumab Concentrations to Guide Anti-TNF Precision Dosing: A Pilot StudyPaul A G de Klaver, Ron J Keizer, Rob Ter Heine, et al.
British Journal of Clinical Pharmacology|September 27, 2018
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedureLoek A W de Jong, Fortuné M K Elekonawo, Philip R de Reuver, et al.
Digestive Diseases and Sciences|March 15, 2023
Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's DiseaseTessa Straatmijer, Vince B C Biemans, Dirk Jan A R Moes, et al.
Therapeutic Drug Monitoring|January 23, 2026
Tailoring Eculizumab Treatment: Evaluation of Model-Informed Precision Dosing for Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic SyndromeAstrid Heida, Mendy Ter Avest, Ron J Keizer, et al.
Pageof 16